News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
361–396
Matches
19719
Sources here
16
Companies here
35
Search results Stored financial headlines

Active search

19719 matching headlines

Ticker or company: HARMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Great Lakes Advisors LLC Makes New $7.56 Million Investment in Home BancShares, Inc. $HOMB

Great Lakes Advisors LLC recently acquired a new position in Home BancShares, Inc. (NYSE:HOMB), purchasing 264,951 shares valued at approximately $7.56 million. This investment comes as Home BancShares exceeded earnings and revenue expectations in its last quarterly report and increased its quarterly dividend. Analysts …

HOMB main company
Sharemaestro market context Trend signal active 52 weeks +7.2% HOMB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eagle Health Investments LP Acquires Shares of 624,676 BioMarin Pharmaceutical Inc. $BMRN

Eagle Health Investments LP has acquired 624,676 shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) in the second quarter, making it their fifth-largest holding. This acquisition, valued at approximately $35.7 million, contributes to institutional investors collectively owning 98.71% of BioMarin. The news follows BioMarin's agreement to …

BMRN main company
Sharemaestro market context Trend signal active 52 weeks +15.0% BMRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of "Hold" from Analysts

Analysts have issued a consensus "Hold" rating for Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), with an average 12-month price target significantly higher than its current trading price. Institutional investors and hedge funds hold a substantial portion of the company's stock, with many increasing their positions recently. …

VRCA main company
Sharemaestro market context Price below Trend Line 52 weeks -9.1% VRCA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Denali Advisors LLC Purchases 29,700 Shares of Harmony Biosciences Holdings, Inc. $HRMY

Denali Advisors LLC has significantly increased its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) by purchasing an additional 29,700 shares, bringing its total holdings to 89,600 shares valued at approximately $3.26 million. This move comes as Harmony Biosciences reported strong quarterly earnings, surpassing analyst …

HRMY main company
Sharemaestro market context Trend signal active 52 weeks +0.7% · Next-week setup negative 42.4% HRMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

First Mid Bancshares, Inc. (NASDAQ:FMBH) Given Average Recommendation of "Moderate Buy" by Analysts

First Mid Bancshares, Inc. (NASDAQ:FMBH) has received a "Moderate Buy" consensus recommendation from analysts, with an average twelve-month target price of $54.6250. Several research firms have recently updated their ratings and price targets, generally increasing their objectives for the stock. Institutional investors have also …

FMBH main company
Sharemaestro market context Trend signal active 52 weeks +32.0% FMBH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DCF Advisers LLC Purchases New Holdings in Regeneron Pharmaceuticals, Inc. $REGN

DCF Advisers LLC has acquired a new stake of 9,250 shares in Regeneron Pharmaceuticals (NASDAQ:REGN), valued at approximately $5.77 million, making it their 14th largest holding. This comes as Regeneron reported strong quarterly earnings, beating estimates with $14.29 EPS and a 16.7% year-over-year revenue …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Linde PLC (LIN) Director Paula Reynolds Buys 100 Shares in Recen

Linde PLC Director Paula Reynolds recently bought 100 shares at $479.12 each, increasing her total holdings to 715.922 shares, signaling confidence in the company. While Linde has seen more insider selling than buying over the past year, Reynolds's purchase, combined with the stock being …

LIN main company
Sharemaestro market context Trend signal ended 52 weeks +1.6% · Next-week setup positive 61.8% LIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diversify Advisory Services LLC Purchases Shares of 5,112 L3Harris Technologies Inc $LHX

Diversify Advisory Services LLC recently acquired 5,112 shares of L3Harris Technologies (NYSE: LHX) worth approximately $1.55 million in Q2. Institutional investors collectively own 84.76% of the company, which reported strong Q2 earnings of $3.13 EPS, beating estimates, and revenue growth of 8.4%. Despite shares …

LHX main company
Sharemaestro market context Price below Trend Line 52 weeks +7.5% LHX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ascendis Pharma (ASND) Reports Earnings And Trial Updates, Is It Fully Priced?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Ascendis Pharma earnings and trial updates set the stage Ascendis Pharma (NasdaqGS:ASND) caught investor attention after reporting second quarter 2026 results on August 13, …

ASND main company
Sharemaestro market context Trend signal active 52 weeks +27.9% ASND stored weekly price path from 22 Aug 2025 to 14 Aug 2026

410,699 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Deutsche Bank AG

Deutsche Bank AG has acquired a new position of 410,699 shares in West Pharmaceutical Services, Inc. (NYSE:WST), valued at approximately $147.44 million. This acquisition makes Deutsche Bank AG a significant institutional holder with about 0.58% of the company's stock. The article also details other …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Danske Bank A S Invests $46.11 Million in The Hartford Insurance Group, Inc. $HIG

Danske Bank A S has invested $46.11 million in The Hartford Insurance Group, Inc. by acquiring 347,961 shares, representing 0.13% ownership. Other institutional investors have also made significant moves, while analysts have issued various ratings and price targets for HIG. The article also details …

HIG main company
Sharemaestro market context Trend signal active 52 weeks +4.8% · Next-week setup positive 59.5% HIG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

15,957 Shares in The Hartford Insurance Group, Inc. $HIG Acquired by Aurora Investment Counsel

Aurora Investment Counsel recently acquired a new position in The Hartford Insurance Group, Inc. (NYSE:HIG), purchasing 15,957 shares valued at approximately $2.115 million. This move is part of broader institutional interest, with several other hedge funds also modifying their holdings in the insurance provider. …

HIG main company
Sharemaestro market context Trend signal active 52 weeks +4.8% · Next-week setup positive 59.5% HIG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Will Connect Biopharma (CNTB) Breathe Easy After Seabreeze Trials?

Connect Biopharma Holdings Limited (CNTB) is developing a drug to treat acute exacerbations in asthma and COPD, two prevalent respiratory conditions. The article indicates that further details about their progress, likely concerning the "Seabreeze Trials," are restricted to paid subscribers of RTT Biotech Investor …

CNTB main company
Sharemaestro market context Price above Trend Line 50 weeks +45.7% · Next-week setup negative 44.3% CNTB stored weekly price path from 5 Sep 2025 to 14 Aug 2026

Great Lakes Advisors LLC Invests $8.15 Million in Jazz Pharmaceuticals PLC $JAZZ

Great Lakes Advisors LLC has acquired a new stake of $8.15 million in Jazz Pharmaceuticals PLC, purchasing 33,804 shares in the second quarter. This move makes Great Lakes Advisors LLC own approximately 0.05% of the company's stock. The article also details recent insider stock …

JAZZ main company
Sharemaestro market context Trend signal active 52 weeks +99.0% · Next-week setup positive 58.7% JAZZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

637,500 Shares in Corvus Pharmaceuticals, Inc. $CRVS Bought by DCF Advisers LLC

DCF Advisers LLC recently acquired a significant stake of 637,500 shares in Corvus Pharmaceuticals (NASDAQ:CRVS), valued at approximately $9.5 million. This purchase makes Corvus the sixth largest holding in DCF Advisers' portfolio, representing 1.7% of their total assets. The article also notes recent insider …

CRVS main company
Sharemaestro market context Price below Trend Line 52 weeks +168.3% · Next-week setup positive 57.2% CRVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 1-Year High - What's Next?

Eton Pharmaceuticals (NASDAQ:ETON) recently hit a new 52-week high of $63.83, with its stock trading at $61.48. This surge follows positive analyst upgrades and strong quarterly earnings, where the company reported $0.43 EPS, significantly beating estimates, and revenue of $37.59 million. Despite insider stock …

ETON main company
Sharemaestro market context Trend signal active 52 weeks +240.2% · Next-week setup positive 57.2% ETON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TOYO H1 2026 Profit Soars With Higher Cell & Module Shipments

TOYO Co., Ltd. reported a significant increase in revenue and profit for the first half of 2026, driven by higher solar cell and module shipments, particularly from its new Texas facility. The company's net income soared to $45.8 million, and gross profit improved by …

TOYO main company
Sharemaestro market context Price below Trend Line 52 weeks +21.2% TOYO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Flossbach Von Storch SE Makes New Investment in The Charles Schwab Corporation $SCHW

Flossbach Von Storch SE has made a significant new investment in The Charles Schwab Corporation, purchasing over 10.7 million shares valued at approximately $987.93 million, making it their sixth-largest holding. Institutional investors collectively own 84.38% of Charles Schwab's stock, and analysts have set a …

SCHW main company
Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup positive 59.9% SCHW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intchains Group | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Ma Weiping - moomoo

This document is an amendment to a Statement of changes in beneficial ownership of securities (Form 4) for Director Ma Weiping of Intchains Group. It indicates a correction or update regarding the director's holdings or transactions in the company's securities. The specific details of …

ICG main company
Sharemaestro market context Price below Trend Line 52 weeks -58.1% ICG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Charter completes Liberty Broadband deal with Cox; could affect Cox customers in Acadiana

Charter Communications has completed its deal with Cox Communications and the acquisition of Liberty Broadband Corporation. This transaction means that former Cox communities will transition to Spectrum products, pricing, and branding. Charter's President & CEO Chris Winfrey will discuss the benefits for customers, communities, …

CHTR main company
Sharemaestro market context New activity signal 52 weeks -44.4% CHTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP

Aurora Investment Counsel has acquired a new stake of 26,890 shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) during the second quarter, valued at approximately $2.23 million. This comes as several other institutional investors have also adjusted their holdings in the specialty pharmaceutical company. ANI Pharmaceuticals …

ANIP main company
Sharemaestro market context Price below Trend Line 52 weeks -15.9% ANIP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Charles Schwab (SCHW) Stock Fair Value Rises After Strong Q2 And Analyst Target Increases

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Charles Schwab's updated model now points to a Fair Value price target of US$125.00, compared with the previous US$116.16 figure. Analysts link this …

SCHW main company SCHW34 main company SCHW main company SCHW main company
Sharemaestro market context Trend signal started 52 weeks +3.6% · Next-week setup negative 43.7% SCHW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback

Aurinia Pharmaceuticals Inc. recently reported second-quarter 2026 results showing higher revenue and earnings year over year, reiterated its 2026 revenue and net product sales guidance, completed a large share buyback program, and finalized a settlement with Teva Pharmaceuticals that delays U.S. generic voclosporin entry …

AUPH main company
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup positive 55.9% AUPH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SK Hynix Reaches Tentative Deal With Union on Wages, Report Says

SK Hynix Inc. and its labor union have reached a tentative wage and collective bargaining agreement, which includes a 6.3% salary increase. A significant change in the agreement is that profit-sharing bonuses will now be paid 40% in cash and 60% in company shares, …

SKHY main company
Sharemaestro market context Stored weekly price path 6 weeks -1.0% · Next-week setup negative 23.7% SKHY stored weekly price path from 10 Jul 2026 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context